July 21, 2026

Alvotech (ALVO) Stock Analysis: Exploring a Potential 328% Upside in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based biotech firm specializing in biosimilar medicines, is capturing investor attention with its remarkable potential upside of 328.15%. As a player in the Healthcare sector, specifically within..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: An Investor’s Guide to 22.97% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its focus on rare disorders and a promising development pipeline. Based..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 62.3% Upside Potential in Biotech Innovation

Investors looking at the healthcare sector, particularly in the biotechnology industry, may find Zai Lab Limited (NASDAQ: ZLAB) a compelling opportunity. With a current market capitalization of $2.32 billion, this..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 22% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a biopharmaceutical company focused on neuroscience, is currently capturing the attention of investors with its potential for substantial upside. Based in Burnaby, Canada, Xenon is..

Warby Parker Inc. (WRBY) Investor Outlook: Analyzing a 22.63% Potential Upside in the Healthcare Sector

Warby Parker Inc. (NYSE: WRBY), a trailblazer in the eyewear industry with a strong presence in both retail and e-commerce across the United States and Canada, is drawing significant attention..

PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a prominent player in the healthcare sector, particularly within the medical devices industry, is drawing investor attention with its innovative surgical robotics technology and a..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 30% Potential Upside Amid Robust Growth

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is attracting significant investor attention as it navigates the competitive biotechnology landscape, focusing on neurological and rare disease treatments. This article examines the company’s current..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 10.83% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (ICUI), a prominent player in the Healthcare sector specializing in Medical Instruments & Supplies, offers promising opportunities for investors seeking growth in the medical devices space. Headquartered..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking a 10.78% Potential Upside for Investors

For investors seeking exposure in the healthcare sector, Haemonetics Corporation (NYSE: HAE) presents a compelling opportunity. With a market capitalization of $3.55 billion, this Boston-based medical technology firm stands out..

Perrigo Company plc (PRGO): Exploring a 55% Upside Potential Amidst High Dividend Yields

Perrigo Company plc (NYSE: PRGO), a stalwart in the healthcare sector, stands as a prominent player in the drug manufacturers industry, focusing on specialty and generic medications. Headquartered in Dublin,..

Ruffer Investment Company adapts to a more volatile market regime

Ruffer Investment Company is adjusting its portfolio strategy as unstable inflation, geopolitical risk and weaker traditional safeguards reshape global markets...

Matchtech targets a critical workforce constraint in UK renewables

Matchtech is positioning its managed recruitment services to help UK renewable energy companies address skills shortages, multi-site hiring pressure and long-term workforce risk...

Smiths Group completes £760m pension buy-in with M&G

Smiths Group has completed a £760 million buy-in for its pension scheme, covering more than 10,000 members and fully insuring c.17,000 members...

Spire Healthcare to publish 2026 interim results on 9 September

Spire Healthcare will announce interim results for the six months ended 30 June 2026 on 9 September 2026...

Mitie Q1 revenue rises 10% as contract wins reach £1.6bn

Mitie reported higher first-quarter revenue, stronger contract wins and a larger bidding pipeline, while net debt and cash outflow remained controlled...

Frasers Group exceeds 30% ownership threshold in HUGO BOSS

Frasers Group has increased its holding in HUGO BOSS to 30.28% after further share acquisitions under its voluntary takeover offer...

Kier expects FY26 results at top end of market expectations

Kier Group expects FY26 revenue and profit to be at the top end of market expectations, supported by a higher order book and strong.....

Compass Group reports continued strong quarterly revenue growth

Compass Group reported 7.1% organic revenue growth in the third quarter and said it remains on track for another year of strong earnings growth...

Brunner Investment Trust reports 5.6% NAV return and raises dividend

Brunner Investment Trust reported half-year NAV total return growth of 5.6% for the six months to 31 May 2026, trailing a 12.0% benchmark rise in a market dominated by AI-led..

Equipmake FY26 revenue more than doubles as trading improves

Equipmake Holdings has issued a trading update showing strong improvement in FY26, with expected revenue of about £8.2 million and second-half adjusted EBITDA profitability. The electrification specialist reported healthier gross..
Search

Funds

July 21, 2026

Ruffer Investment Company adapts to a more volatile market regime

Ruffer Investment Company is adjusting its portfolio strategy as unstable inflation, geopolitical risk and weaker traditional safeguards reshape global markets...

Matchtech targets a critical workforce constraint in UK renewables

Matchtech is positioning its managed recruitment services to help UK renewable energy companies address skills shortages, multi-site hiring pressure and long-term workforce risk...

Smiths Group completes £760m pension buy-in with M&G

Smiths Group has completed a £760 million buy-in for its pension scheme, covering more than 10,000 members and fully insuring c.17,000 members...

Spire Healthcare to publish 2026 interim results on 9 September

Spire Healthcare will announce interim results for the six months ended 30 June 2026 on 9 September 2026...

Mitie Q1 revenue rises 10% as contract wins reach £1.6bn

Mitie reported higher first-quarter revenue, stronger contract wins and a larger bidding pipeline, while net debt and cash outflow remained controlled...

Frasers Group exceeds 30% ownership threshold in HUGO BOSS

Frasers Group has increased its holding in HUGO BOSS to 30.28% after further share acquisitions under its voluntary takeover offer...

Kier expects FY26 results at top end of market expectations

Kier Group expects FY26 revenue and profit to be at the top end of market expectations, supported by a higher order book and strong.....

Compass Group reports continued strong quarterly revenue growth

Compass Group reported 7.1% organic revenue growth in the third quarter and said it remains on track for another year of strong earnings growth...

Brunner Investment Trust reports 5.6% NAV return and raises dividend

Brunner Investment Trust reported half-year NAV total return growth of 5.6% for the six months to 31 May 2026, trailing a 12.0% benchmark rise in a market dominated by AI-led technology stocks. The trust declared a second interim dividend of 6.75p, maintained its progressive income record, and continued selective share buybacks amid a persistent discount...

Equipmake FY26 revenue more than doubles as trading improves

Equipmake Holdings has issued a trading update showing strong improvement in FY26, with expected revenue of about £8.2 million and second-half adjusted EBITDA profitability. The electrification specialist reported healthier gross margins, a cash balance of roughly £2.0 million, and an order book above £8 million, with momentum continuing into the new financial year...
Search

Funds

July 21, 2026

FTSE 100

Funds